Join the DDA or

Stanek (levodopa/carbidopa/entacapone) out of stock

Consider generic prescribing

March 31st 2020

Tagged: Clinical guidance news Dispensary guidance news

By Ailsa Colquhoun

Clinicians and dispensers are advised that Stanek (levodopa/carbidopa/entacapone) tablets (various strengths) are out of stock until mid-June/end-July.

Supplies of Sastravi or Stalevo tablets, which are considered equivalent, continue to remain available. Clinicians should consider prescribing levodopa/carbidopa/entacapone tablets generically: medicines for Parkinson’s disease are not mandated to be prescribed by brand, although this may suit some very brittle patients.

In the event of a shortage, the maintenance of supply of the drug is more important than the brand; and switching of brands is preferable to changing a patient’s regimen.

When switching brands, patients should be reassured that they are receiving the same treatment, counselled on any changes and monitored for side effects/change in disease control.

The NHS has also updated the resupply dates for a number of drugs.